BLAC Bellevue Life Sciences Acquisition Corp. Common Stock

USD 10.70 0.00 0
Icon

Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) Stock Analysis and Price Targets

COMMON STOCK | Shell Companies | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 10.70

0.00 (0.00)%

USD 0.10B

0.01M

N/A

N/A

Icon

BLAC

Bellevue Life Sciences Acquisition Corp. Common Stock (USD)
COMMON STOCK | NSD
USD 10.70
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.10B

N/A

USD 10.70

Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) Stock Forecast

N/A

Based on the Bellevue Life Sciences Acquisition Corp. Common Stock stock forecast from 0 analysts, the average analyst target price for Bellevue Life Sciences Acquisition Corp. Common Stock is not available over the next 12 months. Bellevue Life Sciences Acquisition Corp. Common Stock’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Bellevue Life Sciences Acquisition Corp. Common Stock is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Bellevue Life Sciences Acquisition Corp. Common Stock’s stock price was USD 10.70. Bellevue Life Sciences Acquisition Corp. Common Stock’s stock price has changed by +0.00% over the past week, +0.56% over the past month and +5.84% over the last year.

No recent analyst target price found for Bellevue Life Sciences Acquisition Corp. Common Stock
No recent average analyst rating found for Bellevue Life Sciences Acquisition Corp. Common Stock

Company Overview Bellevue Life Sciences Acquisition Corp. Common Stock

Bellevue Life Sciences Acquisition Corp. focuses on effecting a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company intends to acquire companies in the he...Read More

N/A

10900 NE 4th Street, Bellevue, WA, United States, 98004

0

December

USD

USA

Adjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC)

Loading...

Unadjusted Closing Price for Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC)

Loading...

Share Trading Volume for Bellevue Life Sciences Acquisition Corp. Common Stock Shares

Loading...

Compare Performance of Bellevue Life Sciences Acquisition Corp. Common Stock Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BLAC

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bellevue Life Sciences Acquisition Corp. Common Stock (Sector: Shell Companies )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
DWAC
Digital World Acquisition Corp 0.00 (0.00%) USD1.37B N/A -44.56

ETFs Containing BLAC

Symbol Name BLAC's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Bellevue Life Sciences Acquisition Corp. Common Stock (BLAC) Stock

Stock Target Advisor's fundamental analysis for Bellevue Life Sciences Acquisition Corp. Common Stock's stock is Bearish.

Unfortunately we do not have enough data on BLAC's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BLAC's stock to indicate what its average analyst target is.

BLAC stock's Price/Earning ratio is 214.00. Our analysis grades BLAC stock's Price / Earning ratio at F. This means that BLAC stock's Price/Earning ratio is above 85% of the stocks in the Shell Companies sector in the NSD exchange. Based on this BLAC may be a overvalued for its sector.

The last closing price of BLAC's stock was USD 10.70.

The most recent market capitalization for BLAC is USD 0.10B.

Unfortunately we do not have enough analyst data on BLAC's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Bellevue Life Sciences Acquisition Corp. Common Stock's stock.

As per our most recent records Bellevue Life Sciences Acquisition Corp. Common Stock has 0 Employees.

Bellevue Life Sciences Acquisition Corp. Common Stock's registered address is 10900 NE 4th Street, Bellevue, WA, United States, 98004.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...